The differential production of transcript isoforms from gene loci is a key mechanism in multiple biological processes and pathologies. Although this has been exhaustively shown at RNA level, it remains elusive at protein level. Here, we describe a new pipeline ORQAS (ORF quantification pipeline for alternative splicing) for the translation quantification of individual transcript isoforms using ribosome-protected mRNA fragments (Ribosome profiling). We found evidence of translation for 40-50% of the expressed transcript isoforms in human and 50% in mouse, with 53% of the expressed genes having more than one translated isoform in human, and 33% in mouse.
Introduction
The alternative processing of transcribed genomic loci through transcript initiation, splicing, and polyadenylation, determine the transcript repertoire of cells (Brown et al. 2014) . Differential production of transcript isoforms, especially through the mechanism of alternative splicing, is crucial in multiple biological processes such as cell differentiation, acquisition of tissue-specific functions, and DNA repair (Fiszbein and Kornblihtt 2017; Baralle and Giudice 2017; Shkreta and Chabot 2015) , as well as in multiple pathologies (Ward and Cooper 2010; Singh and Eyras 2017; Cummings et al. 2017) . Although analysis of RNA sequencing (RNA-seq) data from multiple samples has indicated a large diversity of transcript molecules (Pertea et al. 2018) , genes express mostly one single isoform in any given condition and this isoform may change across conditions (Gonzàlez-Porta et al. 2013; Sebestyén et al. 2015) .
Computational and in-vitro studies have provided evidence that a change in relative isoform abundances can lead to the production of protein variants that impact the network of proteinprotein interactions in different contexts (Buljan et al. 2012; Yang et al. 2016; Climente-González et al. 2017; Wojtowicz et al. 2007) . In contrast, quantitative proteomics of naturally occurring proteins has identified much fewer protein variants than those predicted with RNA sequencing (Ezkurdia et al. 2015; Liu et al. 2017) . Using state-of-the arts proteomics, it was recently shown that splicing changes at RNA level lead to changes in the sequence and abundance of proteins produced, although this was detectable for a limited number of transcripts (Liu et al. 2017) . The difficulty in establishing a correspondence between transcript and protein variation may be due to limitations in current proteomics technologies, but also to the stability and translation regulation of transcripts (Maslon et al. 2014; Braun and Young 2014) . Despite the large body of evidence describing its functional relevance (see e.g. (Baralle and Giudice 2017) ), it is still debated whether differential splicing leads to fundamentally new proteins and how widespread protein variation might be (Tress et al. 2017a; Blencowe 2017; Tress et al. 2017b ). Of particular interest are microexons, which can be as short as 3 nucleotides and carry out conserved neuronal-specific functions, and whose misregulation is linked to autism Irimia et al. 2014; Quesnel-Vallieres et al. 2016 ).
However, despite their involvement in protein-protein interactions (Ellis et al. 2012; Irimia et al. 2014 ), the detection of protein variation associated to differential microexon inclusion using unbiased proteomics is currently not possible.
Sequencing of ribosome-protected RNA fragments, i.e. ribosome profiling, provides information on the messengers being translated in a cell. In particular, it allows the identification of multiple translated open reading frames (ORFs) in the same gene and the discovery of novel translated genes (Ingolia et al. 2009; Michel et al. 2012; Ruiz-Orera et al. 2014 . However, ribosome profiling studies have been mainly oriented to gene-level analysis (Ingolia et al. 2009; Gonzalez et al. 2014; Ruiz-Orera et al. 2014) . Recently, reads from ribosome profiling were mapped across the exon-exon junctions of alternative splicing events (Weatheritt et al. 2016) , suggesting that alternative splicing products may be engaged by ribosomes and potentially translated to produce different protein isoforms. A potential limitation of that approach is that ribosomal profiling reads also contain signals from native, non-ribosomal RNA-protein complexes (Ji et al. 2016) . As exon boundaries are profusely bound by RNA binding proteins and splicing factors (Witten and Ule 2011) , the mapping of ribosome reads to these regions is not necessarily indicative of active translation. Additionally, ribosome activity is associated to signal periodicity and uniformity along open reading frames (Ji et al. 2015) , which has not yet been tested in relation to transcript isoforms and alternative splicing. Thus, the extent to which alternative splicing, and in particular microexon inclusion, leads to the translation of alternative ORFs remains largely unknown.
In this article, we describe a new method, ORQAS (ORF quantification pipeline for alternative splicing), to quantify translation abundance at individual transcript level from ribosome profiling taking into account Ribosome signal periodicity and uniformity per isoform. We validated the translation quantification of isoforms using independent data from polysomal fractions and proteomics. We further found a concordance between differential splicing and differential translation, and obtained evidence for the differential translation of microexons that is conserved between human and mouse. ORQAS provides a powerful strategy to study the impacts of differential RNA processing in translation.
Results

Translation Abundance estimation at isoform level from Ribo-seq
We developed a new method, ORQAS (ORF quantification pipeline for alternative splicing), for the estimation of isoform-specific translation abundance (Fig. 1a) (Methods) . ORQAS quantifies the abundance of open reading frames (ORFs) in RNA space from RNA sequencing (RNA-seq) in transcript per million (TPM) units, and assigns ribosome sequencing (Ribo-seq) reads to the same ORFs using RiboMap (Wang et al. 2016) . After the assignment of Ribo-seq reads to isoformspecific ORFs, ORQAS calculates for each ORF two essential metrics to determine their potential translation: Uniformity, calculated as a proportion of the maximum entropy of the read distribution, and the 3nt periodicity along the ORF (Methods).
We analyzed with ORQAS Ribo-seq and matched RNA-seq data from human and mouse glia and glioma (Gonzalez et al. 2014) , mouse hippocampus (Cho et al. 2015) , and mouse embryonic stem cells (Sugiyama et al. 2017 ) (Supp. Table 1 ). To determine which values of uniformity and periodicity would be indicative of an isoform being translated, we selected as positive controls genes with a single annotated ORF and with evidence of protein expression in all 37 tissues recorded in the Human Protein Atlas (THPA) (Uhlén et al. 2015) . We considered translated those ORFs within the 90% of the periodicity and uniformity distribution of these positive controls (Fig.   1b) (Supp. Fig. 1 ). This produced a total of 20709-20785 translated ORFs in human, and 13,019-17,515 in mouse (Supp. Table 2 ). Interestingly, a large fraction of the expressed protein-coding genes had multiple translated isoforms: 52,3%-54,9% of the genes in human (Figs. 1c and 1d ) and 29.1%-35.9% in mouse (Supp. Figure 2) .
Overall, the majority of translated isoforms correspond to either single-isoform genes or the isoform with the highest expression in a sample (main isoform) (Fig. 1d ). However, from those genes with multiple isoforms expressed at the RNA level, 3,471-3,570 (52.6%-55.5%) of genes in human and 577-898 (27.6-34%) in mouse have an alternative isoform translated (Fig. 1d) . From all translated isoforms, 47.3%-49.2% in human, and 28.3%-34.9% in mouse, correspond to alternative isoforms (secondary or other isoform, Fig. 1d ). In genes with multiple isoforms, the main isoform showed the highest average Ribo-seq coverage compared to secondary isoforms, albeit not as high as for the single-ORF genes used as positive controls (Fig. 1e) . As a quality control, we considered the proportion of isoforms with low or no RNA expression that fell inside our periodicity and uniformity cutoffs and found only 0.7-0.9% across the human samples and 0.1-1.5% in the mouse samples (Supp. Table 3 ).
Ribosome profiling discriminates translation abundance at isoform level
As an initial validation of the estimation of isoform-specific translation, we compared our predictions in human with immunohistochemistry data available from The Human Protein Atlas (Uhlén et al. 2015) . We observed that genes with translated isoforms are more frequently validated at all levels of protein expression (Fig. 2a) . Furthermore, the majority (96%) of genes with translated ORFs show some evidence of protein expression using a combination of protein features (Fig. 2b) . To further validate our approach, we compared the translated isoforms predicted with ORQAS with the sequencing of RNA from polysomal fractions from the same human neuronal and embryonic stem cell samples (Blair et al. 2017) . ORQAS predicted 27,552 translated isoforms in stem cells, and 25,034 in neurons (Supp. Fig. 3 ). We found that translated isoforms were enriched in polysomal fractions, whereas isoforms with RNA expression but not predicted to be translated with ORQAS were enriched in monosomal fractions (Fig. 2c) , providing further support to our predictions. This is also consistent with a small proportion of our predicted translated isoforms to be associated with NMD targets, which are generally associated with monosomes (Kim et al. 2017 ).
Cross-species conservation is a strong indicator of stable protein production (Ezkurdia et al. 2014 ).
We thus decided to test the conservation of our translated isoforms in human and mouse, using glia and glioma samples available for both species. To this end, we used an optimization method to determine the human-mouse protein isoform pairs most likely to be functional orthologs (Methods) (Fig. 2d) . From 15824 human-mouse 1-to-1 gene orthologs, we identified 18574 humanmouse protein isoform pairs representing potential functional orthologs. Moreover, 7,112 (64%) of the 1-to-1 gene orthologs had more than one orthologous isoform pair. We found that orthologous isoform pairs were significantly enriched in translated isoforms in both species (p-value < 2.2e-16 in all datasets) ( Fig. 2e) , providing further support for our predictions.
To perform an additional validation of our findings, we considered isoform-specific regions ( Fig.   3a ). We identified sequences that are unique to a specific isoform, since evidence mapped to these regions can be unequivocally assigned to the isoform. Additionally, we defined isoformspecific ORFs as sequences shared between two isoforms but with a different frame in each isoform, since protein evidence mapped to it can be confidently assigned to a specific ORF. Both region types in translated isoforms showed a higher density of reads per nucleotide compared with other isoforms (Fig. 3b) (Supp, Fig. 4a ).
We further used peptides from Mass Spectrometry (MS) experiments (Vizcaíno et al. 2016 ) to match our predictions from Ribo-seq from the same tissue type (Methods). Overall we validated 86%-87% of translated single-ORF genes. Validation rate decreased with region length (Fig. 3c ), as expected for MS experiments (Ezkurdia et al. 2014 ).
Additionally, since ORQAS quantification is performed for the entire ORF and not looking at specific regions within the ORF, we used the raw read data to validate the unique sequence regions. In total, 91-97% of unique sequence regions of length >200nt harbored uniquely mapping Ribo-seq reads ( Fig. 3d ) (Supp Fig. 4b ), and 87-89% unique ORF regions of length > 200nt contained P-sites predicted from the mapped reads (Supp, Fig. 4c ). Overall, we were able to validate 56-80% of the isoform-specific sequence regions tested and 48%-73% of the isoformspecific ORFs tested.
In summary, from all the protein-coding transcript isoforms considered from the annotation (84,024 in human and 48,928 in mouse), 58-59% in human and 63-65% in mouse showed RNA expression > 0.1 TPM (Supp. Table 3 ). From these expressed isoforms, about 40% in human, 41-54% in mouse, were predicted to be translated by ORQAS, and 23-43% were validated using independent data, including conservation (Fig. 3e) . Furthermore, about 10% of all the annotated alternative isoforms in human and mouse had evidence of translation and these represented 60% of all translated isoforms (Fig. 3f ) (Supp Table 4 ). Our analyses thus indicate that, although they are a small fraction of all expressed transcripts, alternative transcript isoforms are often translated into protein.
Conserved impact of differential splicing on translation
Differential splicing is often assumed to lead to a measurable difference in protein production.
However, at genome scale, this has only been shown for a limited number of cases (Liu et al. 2017 ). We addressed this question using our more sensitive approach based on Ribo-seq. We used SUPPA (Alamancos et al. 2015; Trincado et al. 2018 ) to obtain 37,676 alternative splicing events in human and 17,339 in mouse that covered protein coding regions (Methods). Using the same SUPPA engine to convert isoform abundances to event inclusion values (Alamancos et al. 2015; Trincado et al. 2018) , we estimated the proportion of translation abundance, relative abundance (RA), explained by a particular alternative splicing event, using the isoform translation abundances (Fig. 4a) . Accordingly, in analogy to a relative inclusion change (ΔPSI) in RNA space, we were able to measure the relative differences in ribosome space in relation to the inclusion or exclusion of particular alternative exons, or ΔRA.
Comparing the glia and glioma samples in human, we found 856 events with a significant change in RNA splicing (|ΔPSI|>0.1 and p-value<0.05), and 590 events with significant differential translation (|ΔRA|>0.1 and p-value<0.05), with a significant overlap of 363 events between them (Jaccard index, z-score=89.386 comparing to the Jaccard index distribution of the overlaps from subsample sets of the same size) (Fig. 4b) . Similarly, in mouse we found an overlap of 179 events (Jaccard index z-score=65.326), between 471 events with a significant change in RNA splicing (|ΔPSI|>0.1 and p-value<0.05) and 240 with significant change in translation (|ΔRA|>0.1 and pvalue<0.05) (Supp. Fig. 5a ). Furthermore, considering the direction of change from all events in RNA and ribosome space, the concordance of the change was found to be significant for human (Pearson R=0.9904, and mouse (Pearson R=0.9937, p-value = 2.113e-170); and in particular for the events that were significant in both tests (Fig. 4c) (Supp. Fig. 5b ).
We further observed a similar proportion of event types changing significantly in RNA and ribosome space, with an enrichment of exon skipping events in human (Fig. 4d) and mouse (Supp. Fig. 5c ). In particular, microexons, defined to be of length ≤51nt (Li et al. 2015) , were enriched in the events changing between glia and glioma in both human (p-values 1.382e-12 for RNA-seq and 5.602e-10 for Ribo-seq) (Fig. 4e ) and mouse (p-values 6.386e-16 for RNA-seq and 3.446e-06 for Ribo-seq) (Supp. Fig. 5d ). We repeated the same analysis using data from human neuronal differentiation (Blair et al. 2017) and found that microexons were also enriched in the comparison between embryonic stem cells and neuronal cells in human for RNA splicing and translation changes (p-values 8.435e-06 for RNA-seq and 6.597e-05 for Ribo-seq) (Fig. 4f) . Furthermore, using RNA sequencing from polysome fractions from the same stem cell and neuronal samples we were able to validate the change in inclusion patterns of microexons under the same conditions (Fig. 4g) . These results provide evidence that differential splicing leads to a qualitative and quantitative change in the proteins produced from a gene locus. Our results are also consistent with a functional relevance of the inclusion of microexons in protein-coding transcripts in neuronal differentiation and their inclusion loss in brain-related disorders Irimia et al. 2014) .
To further test the relevance of our findings, we considered a set of 1,487 alternative exons conserved between human and mouse (Fig. 5a) . A high proportion of them changed in the same direction between glia and glioma (66% in RNA-seq and 78% in Ribo-seq) (Fig. 5b) . Moreover, we observed that microexons were enriched in these concordant changes in both species, with a general trend towards less inclusion in glioma (p-value 5.389e-05 in RNA-seq and 5.521e-4 for Ribo-seq) (Fig. 5c) . Among the microexons with a differential pattern of splicing and translation, we identified one in the gene GOPC, which was linked before to glioblastoma (Charest et al. 2003) , and one in the gene CERS6 (Fig. 5d) . To test further the potential relevance of the identified microexons with conserved differential pattern, we calculated their RNA splicing inclusion patterns across other normal and tumor brain samples. In particular, we analyzed samples from glioblastoma multiforme (GBM) from TCGA (Cancer Genome Atlas Research Network 2008), Neuroblastoma (NB) from TARGET (Pugh et al. 2013) (Fig 5e) , and samples from cortex and hippocampus from GTEX (Carithers et al. 2015) . Microexons with a conserved impact on translation recapitulate the pattern of decreased inclusion in GBM compared with the postmortem normal brain regions (Fig. 5e ). Differentially translated microexons may explain tissue differentiation as well as tumor specific properties, as they differentiate tissues and tumor types (Supp. Fig. 5e ), whereas conserved microexons appear to be more representative of the tissue differentiation (Supp. Fig. 5f ).
Discussion
We have described a new method, ORQAS, to obtain abundance estimates at isoform level in ribosome space (https://github.com/comprna/orqas). ORQAS allows the identification of multiple protein products from a gene and the study of differential translation associated to alternative splicing and differential transcript usage between conditions. Our approach presents several novelties with respect to previous analyses (Blair et al. 2017; Weatheritt et al. 2016; Wang et al. 2016 ): i) we calculated the periodicity and uniformity for each isoform; ii) we validated our predictions using both sequence and ORF specific regions in isoforms, regardless whether these regions could be encoded into an standard alternative splicing event; and iii) we provided an isoform quantification in ribosome space that can be reused with other tools, like SUPPA.
Additionally, ORQAS uses RNA-seq quantification to guide the isoform abundance estimation in ribosome space, unlike previous approaches that used directly Ribo-seq reads to quantify isoforms, which presents important limitations (Blair et al. 2017 ).
We estimated that in total about 40-50% of the protein coding isoforms with RNA expression showed some evidence of translation, and that around 20,700 proteins are produced in human and 13,000-17,500 in mouse in the tested conditions. Additionally, about 5,700-5,800 genes in human, 2,600-3,900 in mouse, produce more than one protein in those conditions. These estimates are far from what is generally predicted from RNA expression only (Pertea et al. 2018 ). This may be explained by the limited coverage of Ribo-seq reads, but may be also due to the fact that RNA-seq artificially amplifies fragments of unproductive RNAs leading to many false positives. Nonetheless, our data indicates that many more ORFs are translated in a given sample than what is detectable by current proteomics methods and the number of protein products are close to estimates using a combination of proteomics and sequence conservation (Ezkurdia et al. 2014) . Importantly, we found that multiple ORFs are translated from the same gene and at different abundances across conditions. Around 40% of the events detected with differential RNA splicing showed consistent measurable changes in Ribo-seq in the same direction, which supports the notion that changes in RNA processing of genes have a widespread impact in the translation of ORFs from a gene. In particular, we found that a pattern of decreased inclusion of microexons in glioma with respect to normal brain samples is recapitulated in translation, providing in vivo evidence that the splicing changes in microexons have an impact in protein production. Microexon inclusion is a hallmark of neuronal differentiation Raj et al. 2014; Trincado et al. 2018) , and glia partly recapitulates the pattern of microexon inclusion found in neurons ). The decreased inclusion of microexons observed in glioma suggests a dedifferentiation pattern as has been described before for other tumors (Sebestyén et al. 2016 ), but could also be indicative of a difference in the content of neuronal cells in the samples compared. In either case, the evolutionary conservation of the change at RNA expression and protein production indicates a conserved functional program between the glia and glioma samples.
Our capacity to predict RNA splicing variations from RNA-seq data currently exceeds our power to evaluate the significance of those events regarding protein production with current proteomics technologies (Wang et al. 2018) . Despite this limitation, mass spectrometry can show for a small number of cases that splicing changes impact the abundance of proteins produced by a gene (Liu et al. 2017) . Our findings are in agreement with these results, and moreover overcome current limitations to determine genome-wide impacts of RNA processing changes on protein production. Furthermore, our analyses indicate that for the majority of genes producing multiple protein isoforms, these do not vary in more than 25% of the length of the most highly expressed isoform, suggesting that for most part, the functional impacts from alternative splicing are mediated by slight modifications in the protein sequences (Ellis et al. 2012) , rather than through the production of essentially different proteins. In summary, ORQAS leverages ribosome profiling to provide a genome-wide coverage of genes and transcript isoforms and allow a more effective testing of the impacts of splicing in protein production, as well as the identification and validation of multiple proteins from the same gene locus.
Methods
Pre-processing of RNA-seq and Ribo-seq datasets
RNA-seq and Ribo-seq datasets were downloaded from Gene Expression Omnibus (GEO) for the following samples: normal glia and glioma from human and mouse (GSE51424) (Gonzalez et al. 2014 ), mouse hippocampus (GSE72064) (Cho et al. 2015) , mouse embryonic stem cells (GSE89011) (Sugiyama et al. 2017) , and three steps of forebrain neuronal differentiation in human (GSE100007) (Blair et al. 2017) . Adapters in RNA-seq and Ribo-seq datasets were trimmed using cutadapt v.1.12 with additional quality filters (-hq = 30 -lq = 10) (Martin 2011) . We further discarded reads that mapped to annotated rRNAs and tRNAs. Remaining reads in RNA-seq and Ribo-seq datasets were filtered by length (>= 26 nucleotides).
Quantification of transcripts and open reading frames
We used the Ensembl annotation v85 for human (hg19) and mouse (mm10) removing pseudogenes, short isoforms (< 200 nt) and annotated isoforms with incomplete 5' or 3' regions.
For the analysis of RNA-seq data we used Salmon v0.7.2 (Patro et al. 2017 ) to quantify transcript abundances in transcripts per million (TPM) units using the annotation of unique open reading frames (ORFs). To quantify coding sequences (CDS) at the isoform level with the Ribo-seq data we applied a modified version of Ribomap (Wang et al. 2016) . As default, Ribomap uses the RNAseq reads aligned to the transcriptome sequences with STAR (Dobin et al. 2013) . Instead, we provided a direct quantification of the ORFs with RNA-seq using Salmon, to be used as priors by RiboMap. We calculated the translation abundances of each ORF based on Ribo-seq in ORFs Per Million (OPM) units, analogously to the TPM units:
where n i is the estimated Ribo-seq counts in ORF i and l i is the effective length of the same ORF.
Identification of actively translated isoform coding sequences
We identified actively translated ORFs by calculating two parameters read periodicity and read uniformity (Ji et al. 2015) . The periodicity is based on the distribution of the reads in the annotated frame and the two alternative ones. In order to calculate the read periodicity, we previously computed the position of the P-site, corresponding to the tRNA binding-site in the ribosome complex. This was obtained by calculating the distance between annotated ATG start codons and the leftmost position covered by Ribo-Seq reads, for each read length, The uniformity was measured as the proportion of maximum entropy (PME) defined by the distribution of reads along the ORF:
Where N represents the total number of reads, N i i is the number of reads in each region i and max(H) is the entropy assuming that the reads are equally distributed across the ORF. The maximum value is 1, and indicates a completely even distribution of reads across codons. These values were obtained for each sample by pooling the replicates and we only considered ORFs with 10 or more assigned Ribo-seq reads, and with RNA-seq abundance TPM > 0.1.
Polysomal fraction analysis
We used RNA-seq from high polysomal, low polysomal and monosomal fractions from embryonic stem cells and neuronal cell culture in human (GSE100007) (Blair et al. 2017 ) to quantify isoforms with Salmon (Patro et al. 2017) . Only ORFs from protein-coding isoforms were used for quantification. For each isoform we calculated the polysomal relative abundance as before (Maslon et al. 2014 ) by dividing the abundance in high polysomal fraction in TPM units, by the sum of abundances in (high and low) polysomes and monosomes.
Validation of isoform-specific regions
We defined two different types of isoform-specific regions that were analysed differently. Isoformspecific sequences are regions with a unique nucleotide sequence among the isoforms of the same gene. Isoform-specific ORFs are defined as regions that will give rise to different amino-acid sequences within the proteins of the same gene, either because of the presence of isoformspecific sequences or frame-shifted common sequences (Fig. 3A) . According to the annotation, we identified 34553 isoforms containing isoform-specific sequences in human and 29447 in mouse and 44298 isoforms containing isoform-specific ORFs in human and 34329 in mouse. For the validation of isoform-specific sequences we considered uniquely mapping Ribo-seq reads from the STAR output falling entirely inside these regions or in the junction of the specific sequence with the common region. Read densities inside those regions where calculated as the total number of uniquely mapping reads in the region divided by the length of the isoform-specific sequence. The validation of isoform-specific ORFs instead was performed using the profiles of counts in each base of the ORF considering the expected position of the P-site. For isoform-specific ORFs the read densities where established as total number of counts in the region divided by the length in nucleotides of the isoform-specific ORFs.
Proteomics evidence in translated isoform coding sequences
We mined the proteomics database PRIDE (Vizcaino et al. 2016) to search for peptide matches to ORFs. We only considered peptide datasets from mouse corresponding to tissues analyzed in this study: brain (PRD000010, PXD000349, PXD001786), hippocampus (PRD000363, PXD000311, PXD001135), and embryonic cell lines (PRD000522). This corresponded to a total of 328,200 peptides. We searched for peptide matches in translated ORFs and only kept peptides that had one perfect match to an ORF and did not have a match with 0, 1 or 2 amino acid mismatches to any other annotated ORF isoform from the same or different genes.
Differential inclusion of events at RNA and translation level
We used SUPPA (Alamancos et al. 2015; Trincado et al. 2018 ) to generate alternative splicing events defined from protein-coding transcripts and covering the annotated ORFs. The relative inclusion of an event was calculated with SUPPA in terms of the transcript abundances (in TPM units) calculated from RNA-seq and in terms of the ORF abundances (in OPM units) calculated from Ribo-seq. The test for significant differential inclusion of the events was applied in the same way for both cases by testing the difference between the observed change between conditions and the observed change between replicates, as described before (Trincado et al. 2018 ).
Calculation of orthologous isoforms
We considered the set of 1-to-1 orthologous genes between human and mouse from Ensembl (v85) (Clamp et al. 2003) . For each pair of orthologous genes we calculated all possible pairwise global alignments between the human and mouse proteins encoded by these genes using MUSCLE (Edgar 2004) . For each alignment we defined a score as the fraction of amino acid matches over the total length of the global alignment, and kept only protein pairs with score >= 0.8.
From all the remaining protein pairs in each orthologous gene pair, we selected the best humanmouse protein pairs using a symmetric version of the stable marriage algorithm (Eyras et al. 2004) red we show the proportion of alternative splicing events calculated with SUPPA from the annotated coding regions in transcripts in human, whereas in blue we show the events that show a significant change using RNA-seq from mouse glia and glioma. Even types are: alternative 3'ss (A3) and 5'ss (A5), alternative first (AF) and last (AL) exon, mutually exclusive (MX) exon, retained introns (RI) and skipping exon (SE). There is significant enrichment for SE events for RNA (Fisher's test p-value = 3.90e-06) and Ribo-seq (p-value = 7.46e-07), for A3 events for RNA (pvalue = 1.02e-05) and Ribo-seq (6.22e-06), for A5 events for RNA (4.55e-03) and Ribo-seq (8.73e-03); and significant depletion for AL events for RNA (1.73e-32) and Ribo-seq (2.43e-43) and for MX events for RNA (6.06e-04) and Ribo-seq (1.83e-03). These proportions for mouse are shown in Supp. 
